期刊文献+

含preS2免疫表位的HBsAg基因质粒的构建及表达 被引量:1

Plasmid construction and expression of Hepatitis B surface antigen gene containing the preS2 immune epitope
下载PDF
导出
摘要 目的 :应用表位设计构建高效表达乙型肝炎表面抗原含preS2免疫表位基因的真核表达质粒。方法 :PCR法从慢性乙型肝炎患者血清中扩增和分离preS2 12 0 - 146表位和S基因片段 ,将两者融合并置于载体pcDNA3 1的巨细胞病 (CMV)启动子作用之下 ,构建真核表达质粒pcDNA -S2S。序列分析和脂质体转染COS - 7细胞瞬时表达鉴定。结果 :序列测定结果表明插入序列与乙型肝炎病毒中国株全基因参照序列 (adr亚型 )一致。COS - 7细胞瞬时表达鉴定实验中 ,ELISA检测到preS2 -Ag和HBsAg的OD450 分别为 0 4 6 9和 0 4 2 6。结论 :应用表位设计成功地构建了含preS2免疫表位基因的重组质粒pcDNA -S2S所构建质粒能高效表达和分泌目的的蛋白。 Objective: To construct the plasmid of high effect expression the Hepatitis B surface middle protein applying for epitope designing.Methods: Isolated the preS2 120-146 epitope and S gene from the serum of chronic Hepatitis B patient by PCR.S gene fused with the preS2 epitope were placed downstream of CMV promoter of the pcDNA3.1 vector,we succeeded in constructing the eukaryotic expression plsmid pcDNA-S2S.The plasmid was identified by sequence analysis and transient transfection into COS-7 cell line by lipoid mediation.Results: Sequence analysis suggested that the inserted gene belongs to adr subtype.ELISA detected the transient expression of the preS2-Ag and HBsAg in the media of COS-7 cells tyranfected with plsmid pcDNA-S2S,the OD 450 values were 0.469 and 0.426 respectively.Conclusion:The plasmid pcDNA-S2S which can express and secret the target protein high effectively was constructed.
出处 《生物技术》 CAS CSCD 2003年第1期1-2,共2页 Biotechnology
基金 吉林省卫生厅医学科研基金资助项目 (2 0 0 0 - 1 68)
关键词 preS2免疫表位 HBsAg基因质粒 构建 表达 乙型肝炎表面抗原 表位设计 hepatits B surface antigen epitope-based designing preS2 immue epitope
  • 相关文献

参考文献3

二级参考文献2

  • 1甘人宝 储美瑾 等.克隆的adr亚型乙型肝炎病毒基因(PADR-1)的核苷酸顺序[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),1984,16(3):316-319.
  • 2琦祖和 阎捃 等.乙型肝炎病毒adrNC-1 DNA的全顺序测定[J].中国科学:B辑,1988,12:1300-1304.

共引文献28

同被引文献19

  • 1Lok AS, McMahon BJ.Chronic hepatitis B [M]. Hepatology,2001,34 (6):1225-1241.
  • 2Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China [J]. J Infect Dis,2009,200 (1):39-47.
  • 3Bertoletti A, Maini MK. Protection or damage:a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection[M]. Curr Opin Microbiol,2000,3(4):387-392.
  • 4Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop[C]. Hepatology,2007,45 (4): 1056-1075.
  • 5Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection[J]. Science,2009,324(5934): 1572-1576.
  • 6Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection[J]. Science,2009,324(5934): 1569-1572.
  • 7Frohlich A, Kisielow J, Schmitz I, et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection [J]. Science,2009,324(5934): 1576-1580.
  • 8Silver JS, Hunter CA. With a little help from their friends: interleukin-21, T cells, and B cells[J]. Immunity,2008,29 (1):7-9.
  • 9Coquet JM, Kyparissoudis K, Pellicci DG, et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production[J]. Immunol,2007,178 (5):2827-2834.
  • 10Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis[J]. J Exp Med,1995,181(3): 1047-1058.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部